Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice
Mitsuko Yuzawa,1 Kyoko Fujita,1 Erika Tanaka,2 Edward C Y Wang21Department of Ophthalmology, Nihon University School of Medicine, Surugadai, Kanda, Chiyoda-ku, Tokyo, Japan; 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd, Marunouchi, Chiyoda-ku, Tokyo, JapanBackground: The importance of...
Guardado en:
Autores principales: | Yuzawa M, Fujita K, Tanaka E, Wang ECY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/836db3b650364f6ba8ae312264a1872e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
por: Tryfon Rotsos, et al.
Publicado: (2010) -
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sobha Sivaprasad, et al.
Publicado: (2008) -
Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration
por: Rung L, et al.
Publicado: (2013) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
por: Nikolaus Feucht, et al.
Publicado: (2008) -
Age-related macular degeneration
por: Querques G, et al.
Publicado: (2011)